Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site

被引:97
|
作者
Durdagi, Serdar [2 ]
Senturk, Murat [1 ]
Ekinci, Deniz [3 ,4 ]
Balaydin, Halis Turker [5 ]
Goksu, Suleyman [6 ]
Kufrevioglu, O. Irfan [6 ]
Innocenti, Alessio [7 ]
Scozzafava, Andrea [7 ]
Supuran, Claudiu T. [7 ]
机构
[1] Ibrahim Cecen Univ Agri, Sci & Art Fac, Dept Chem, TR-04100 Agri, Turkey
[2] Univ Calgary, Dept Biol Sci, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada
[3] Ondokuz Mayis Univ, Fac Agr, Dept Agr Biotechnol, TR-55139 Samsun, Turkey
[4] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany
[5] Artvin Coruh Univ, Fac Educ, TR-08100 Artvin, Turkey
[6] Ataturk Univ, Fac Sci, Dept Chem, TR-25240 Erzurum, Turkey
[7] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
关键词
Carbonic anhydrase; Phenol; Sulfonamide; Dimethoxy-benzene; Phenolic acid; Docking; Enzyme inhibition; ISOZYME-II; CRYSTAL-STRUCTURE; SALICYLIC-ACID; ACTIVATORS; SULFONAMIDES; COUMARINS; DESIGN; AGENTS; ADDUCT; SERIES;
D O I
10.1016/j.bmc.2011.01.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carbonic anhydrases (CAs, EC 4.2.1.1) are inhibited by sulfonamides, inorganic anions, phenols, coumarins (acting as prodrugs) and polyamines. A novel class of CA inhibitors (CAIs), interacting with the CA isozymes I, II (cytosolic) and IX, XII (transmembrane, tumor-associated) in a different manner, is reported here. Kinetic measurements allowed us to identify hydroxy-/methoxy-substituted benzoic acids as well as di-/tri-methoxy benzenes as submicromolar-low micromolar inhibitors of the four CA isozymes. Molecular docking studies of a set of such inhibitors within CA I and II allowed us to understand the inhibition mechanism. This new class of inhibitors binds differently compared to all other classes of inhibitors known to date: they were found between the phenol-binding site and the coumarin-binding site, filling thus the middle of the enzyme cavity. They exploit different interactions with amino acid residues and water molecules from the CA active site compared to other classes of inhibitors, offering the possibility to design CAIs with an interesting inhibition profile compared to the clinically used sulfonamides/sulfamates. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1381 / 1389
页数:9
相关论文
共 49 条
  • [41] Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives
    Altintop, Mehlika Dilek
    Sever, Belgin
    Ozdemir, Ahmet
    Kucukoglu, Kaan
    Onem, Hicran
    Nadaroglu, Hayrunnisa
    Kaplancikli, Zafer Asim
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (13) : 3547 - 3554
  • [42] Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies
    Carta, Fabrizio
    Garaj, Vladimir
    Maresca, Alfonso
    Wagner, Jason
    Avvaru, Balendu Sankara
    Robbins, Arthur H.
    Scozzafava, Andrea
    McKenna, Robert
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (10) : 3105 - 3119
  • [43] New 4-methanesulfonyloxy benzohydrazide derivatives as potential antioxidant and carbonic anhydrase I and II inhibitors: synthesis, characterization, molecular docking, dynamics & ADME studies
    Kose, Aytekin
    Kose, Leyla Polat
    Senol, Halil
    Ulusoy-Guzeldemirci, Nuray
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1325
  • [44] Probing the 'bipolar' nature of the carbonic anhydrase active site: Aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms
    Krasavin, Mikhail
    Korsakov, Mikhail
    Dorogov, Mikhail
    Tuccinardi, Tiziano
    Dedeoglu, Nurcan
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 101 : 334 - 347
  • [45] Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: Stereospecific recognition within the active site of an enzyme and its consequences for the drug design
    Temperini, Claudia
    Scozzafava, Andrea
    Vullo, Daniela
    Supuran, Claudiu T.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (10) : 3019 - 3027
  • [46] Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies
    Alim, Zuhal
    Koksal, Zeynep
    Karaman, Muhammet
    PHARMACOLOGICAL REPORTS, 2020, 72 (06) : 1738 - 1748
  • [47] Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies
    Zuhal Alım
    Zeynep Köksal
    Muhammet Karaman
    Pharmacological Reports, 2020, 72 : 1738 - 1748
  • [48] Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with L- and D-histidine and crystallographic analysis of their adducts with isoform II: Engineering proton-transfer processes within the active site of an enzyme
    Temperini, Claudia
    Scozzafava, Andrea
    Vullo, Daniela
    Supuran, Claudiu T.
    CHEMISTRY-A EUROPEAN JOURNAL, 2006, 12 (27) : 7057 - 7066
  • [49] Novel Re(I) tricarbonyl coordination compounds based on 2-pyridyl-1,2,3-triazole derivatives bearing a 4-amino-substituted benzenesulfonamide arm: synthesis, crystal structure, computational studies and inhibitory activity against carbonic anhydrase I, II, and IX isoforms†
    Aimene, Yassine
    Eychenne, Romain
    Mallet-Ladeira, Sonia
    Saffon, Nathalie
    Winum, Jean-Yves
    Nocentini, Alessio
    Supuran, Claudiu T.
    Benoist, Eric
    Seridi, Achour
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 773 - 782